CoChat

Acute Toxicity Study of a Simian Immunodeficiency Virus-Based Lentiviral Vector for Retinal Gene Transfer in Nonhuman Primates

Ikeda, Yasuhiro, Yonemitsu, Yoshikazu, Miyazaki, Masanori, Kohno, Ri-ichiro, Murakami, Yusuke, Murata, Toshinori, Goto, Yoshinobu, Tabata, Toshiaki, Ueda, Yasuji, Ono, Fumiko, Suzuki, Toshimichi, Ageyama, Naohide, Terao, Keiji, Hasegawa, Mamoru, Sueishi, Katsuo, Ishibashi, Tatsuro · 2009 · Human Gene Therapy
Cited by 15

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

A phase 1 clinical trial evaluating the safety of gene therapy for patients with wet age-related macular degeneration (AMD) or retinoblastoma has been completed without problems. The efficacy of gene therapy for Leber's congenital amaurosis (LCA) was reported by three groups. Gene therapy may thus hold promise as a therapeutic method for the treatment of intractable ocular diseases. However, it will first be important to precisely evaluate the efficiency and safety of alternative gene transfer vectors in a preclinical study using large animals. In the present study, we evaluated the acute local (ophthalmic) and systemic toxicity of our simian immunodeficiency virus from African green monkeys (SIVagm)-based lentiviral vectors carrying human pigment epithelium-derived factor (SIV-hPEDF) for transferring genes into nonhuman primate retinas. Transient inflammation and elevation of intraocular pressure were observed in some animals, but these effects were not dose dependent. Electroretinograms (ERGs), including multifocal ERGs, revealed no remarkable change in retinal function. Histopathologically, SIV-hPEDF administration resulted in a certain degree of inflammatory reaction and no apparent structural destruction in retinal tissue. Regarding systemic toxicity, none of the animals died, and none showed any serious side effects during the experimental course. No vector leakage was detected in serum or urine samples. We thus propose that SIVagm-mediated stable gene transfer might be useful and safe for ocular gene transfer in a clinical setting.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/hum.2009.048

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 15

Metadata

Authors
Ikeda, Y., Yonemitsu, Y., Miyazaki, M., Kohno, R.-I., Murakami, Y., Murata, T., Goto, Y., Tabata, T., Ueda, Y., Ono, F., Suzuki, T., Ageyama, N., Terao, K., Hasegawa, M., Sueishi, K., & Ishibashi, T.
Venue
Human Gene Therapy
Published
2009-09
Volume
20
Issue
9
Pages
943-954
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W2042328038
Cited by
15
References
9
FWCI
0.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute Toxicity Study of a Simian Immunodeficiency Virus-Based Lentiviral Vector for Retinal Gene Transfer in Nonhuman Primates. https://app.cochat.ai/papers/10.1089/hum.2009.048
The paper
Ikeda, Y., Yonemitsu, Y., Miyazaki, M., Kohno, R.-I., Murakami, Y., Murata, T., Goto, Y., Tabata, T., Ueda, Y., Ono, F., Suzuki, T., Ageyama, N., Terao, K., Hasegawa, M., Sueishi, K., & Ishibashi, T. (2009). Acute Toxicity Study of a Simian Immunodeficiency Virus-Based Lentiviral Vector for Retinal Gene Transfer in Nonhuman Primates. Human Gene Therapy. https://doi.org/10.1089/hum.2009.048

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.